METHOD AND APPARATUS FOR PROVIDING A PHARMACOKINETIC DRUG DOSING REGIMEN

Patent №

US 11,749,394

Granted

2023-09-05

Filed 2021

Owner

BAXALTA INCORPORATED

+1 more

Lab

AI components

3

ml · planning · evo

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

17374315

Systems and methods providing a clotting factor VIII dosing regimen are disclosed. The systems and methods include determining an estimated pharmacokinetic profile of a patient using a Bayesian model of pharmacokinetic profiles of sampled patients. The systems and methods can determine a first dosing regimen for a first dosing interval including (i) a first dosage and (ii) a first therapeutic plasma protein level in the patient varying over time based at least upon the estimated pharmacokinetic profile. The systems and methods can determine a second dosing regimen for a second dosing interval including (i) a second dosage and (ii) a second therapeutic plasma protein level in the patient varying over time. The estimated pharmacokinetic profile can be adjusted based on previous patient treatments. Further, a user can select which days a dosage is to be applied such that the protein level does not fall below a target trough.

Machine learningPlanningEvolutionary computationG16H 20/17G16C 20/30G16H 50/20G16H 50/50G16H 50/70A61K 49/0004A61P 7/04G06N 7/01+2 more

AI classification

Planning0.99
Evolutionary computation0.98
Machine learning0.75
AI hardware0.45
Vision0.34
Natural language0.02
Knowledge representation0.00
Speech0.00

Ownership

BAXALTA INCORPORATED

assignment · 626040377

TAKEDA PHARMACEUTICAL COMPANY LIMITED

assignment · 626040630

Assignors

KUCHIMANCHI, KAMESWARA RAO, LOEW-BASELLI, ALEXANDRA, SPOTTS, GERALD DICKEY, OH, MYUNGSHIN, HALE, MICHAEL DON, WOLFSEGGER, MARTIN

On an employer assignment, the assignors are typically the inventors.

© 2026 NYSGPT2525 LLC